Baricitinib therapy in Rheumatoid arthritis
Many patients with rheumatoid arthritis do not respond to conventional treatment with methotrexate or alternative disease-modifying antirheumatic drugs
You will learn:
• The overarching principles of rheumatoid arthritis (RA) therapy
• The mechanism of action of Janus kinase inhibitors
• Clinical and real-world evidence for the efficacy and safety of Baricitinib in the patient with RA.
WEBINAR HELD ON 25 JANUARY 2023.
To access this module, please register or login: